These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28096259)

  • 1. Bariatric Surgery Enhances Splanchnic Vascular Responses in Patients With Type 2 Diabetes.
    Honka H; Koffert J; Kauhanen S; Teuho J; Hurme S; Mari A; Lindqvist A; Wierup N; Groop L; Nuutila P
    Diabetes; 2017 Apr; 66(4):880-885. PubMed ID: 28096259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-associated Blunted Subcutaneous Adipose Tissue Blood Flow After Meal Improves After Bariatric Surgery.
    Saari T; Koffert J; Honka H; Kauhanen S; U-Din M; Wierup N; Lindqvist A; Groop L; Virtanen KA; Nuutila P
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1930-1938. PubMed ID: 35363252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
    Aaboe K; Knop FK; Vilsboll T; Vølund A; Simonsen U; Deacon CF; Madsbad S; Holst JJ; Krarup T
    J Clin Endocrinol Metab; 2009 Feb; 94(2):603-8. PubMed ID: 19050053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control after metabolic surgery: a Granger causality and graph analysis.
    Previti E; Salinari S; Bertuzzi A; Capristo E; Bornstein S; Mingrone G
    Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E622-E630. PubMed ID: 28698280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemia and hypertension. Do intestinal hormones play a role?
    Tedde R; Pala A; Melis A; Sechi G; Bilotta F; Realdi G
    Am J Hypertens; 1995 Feb; 8(2):99-103. PubMed ID: 7755955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
    Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
    Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow.
    Honka H; Koffert J; Hannukainen JC; Tuulari JJ; Karlsson HK; Immonen H; Oikonen V; Tolvanen T; Soinio M; Salminen P; Kudomi N; Mari A; Iozzo P; Nuutila P
    J Clin Endocrinol Metab; 2015 May; 100(5):2015-23. PubMed ID: 25734253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
    Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
    Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Hayes TM
    Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?
    Flatt PR
    Diab Vasc Dis Res; 2007 Jun; 4(2):151-3. PubMed ID: 17654450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
    Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
    Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.
    Koffert J; Ståhle M; Karlsson H; Iozzo P; Salminen P; Roivainen A; Nuutila P
    Diabetes Obes Metab; 2018 Jun; 20(6):1384-1390. PubMed ID: 29352513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.